CL 316243 disodium salt

• CAT Number: I013984
• CAS Number: 151126-84-0
• Molecular Formula: C20H18ClNNa2O7
• Molecular Weight: 465.81
• Purity: ≥95%
• Synonyms: sodium 5-((S)-2-(((S)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)benzo[d][1,3]dioxole-2,2-dicarboxylate
• Target: Adrenergic Receptor
• Solubility: Soluble to 100 mM in sterile water
• Storage: Desiccate at -20C
• IUPAC Name: disodium;5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate
• InChI: InChI=1S/C20H20ClNO7.2Na/c1-11(22-10-15(23)13-3-2-4-14(21)9-13)7-12-5-6-16-17(8-12)29-20(28-16,18(24)25)19(26)27;;/h2-6,8-9,11,15,22-23H,7,10H2,1H3,(H,24,25)(H,26,27);;/q;2*+1/p-2
• InChIKey: FUZBPOHHSBDTJQ-UHFFFAOYSA-L
• SMILES: CC(CC1=CC2=C(C=C1)OC(O2)(C(=O)[O-])C(=O)[O-])NCC(C3=CC(=CC=C3)Cl)O.[Na+].[Na+]

CL 316243 Disodium Salt(CAT: I013984) is a highly selective β3-adrenergic receptor agonist, widely used in metabolic and obesity research. By activating β3-adrenergic receptors, it stimulates lipolysis and thermogenesis in adipose tissue, particularly brown adipose tissue (BAT), promoting energy expenditure and weight loss. This compound has been instrumental in elucidating the role of β3-adrenergic pathways in metabolic regulation and the treatment of obesity-related disorders. Its specificity and efficacy make it a valuable tool for studying adrenergic receptor pharmacology, metabolic disease mechanisms, and the development of β3-targeted therapeutics for obesity and diabetes management.